🇪🇺 Refludan in European Union

Refludan (LEPIRUDIN) regulatory status in European Union.

Marketing authorisation

EMA

  • Application: EMEA/H/C/000122
  • Local brand name: Refludan
  • Status: withdrawn

Refludan in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Cardiovascular approved in European Union

Frequently asked questions

Is Refludan approved in European Union?

Yes. EMA has authorised it.

Who is the marketing authorisation holder for Refludan in European Union?

Marketing authorisation holder not available in our data.